A waiver of clinical data under MDR Article 61(10) is possible if the product’s nature, sufficient non-clinical evidence, and risk management justify it. Instead of clinical investigations, manufacturers may rely on technical testing, pre-clinical evaluation, and performance data to demonstrate safety and compliance.